Clozapine-induced hypersalivation: Causes and suggestions for treatment;Hypersalivatie door clozapine: Oorzaken en behandelmogelijkheden

Tijdschrift voor Psychiatrie

Volumn 47, Issue 1, 2005, Pages 39-44

  Christiaens, V ^a,b   Pieters, G ^b,c  

^a UPC Sint Kamillus   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Universitair GGZ Leuven ^*  (Belgium)

Author keywords

Clozapine; Sialorrhea

Indexed keywords

AMITRIPTYLINE; ATROPINE; BENZATROPINE; CLONIDINE; CLOZAPINE; IPRATROPIUM BROMIDE; LOFEXIDINE; PIRENZEPINE; PLACEBO; TERAZOSIN; TRIHEXYPHENIDYL;

ARTICLE; CASE STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG WITHDRAWAL; HUMAN; HYPERSALIVATION; PSYCHOTHERAPY; SALIVA; SCHIZOPHRENIA;

EID: 12344291227     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Antonello, C., & Tessier, P. (1999). Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect. Journal of Psychiatry & Neuroscience, 24, 250.
2. Bai, Y.M., Lin, C.C., Chen, J.Y., e.a. (2001). Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study. Journal of Clinical Psychopharmacology, 21, 608-611.
3. Baum, B.J. (1993). Principles of saliva secretion. Annals New York Academy of Sciences, 694, 17-23.
4. Ben-Aryeh, H., Jungerman, T., Szargel, R., e.a. (1996). Salivary flow-rate and the composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biological Psychiatry, 39, 946-949.
5. Bourgeois, J.A., Drexler, K.G., & Hall, M. J. (1991). Hypersalivation and clozapine. Hospital and Community Psychiatry, 42, 1174.
6. Calderon, J., Rubin, E., & Sobota, W.L. (2000). Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report. International Clinical Psychopharmacology, 15, 49-52.
7. Comley C., Galletly, C., & Ash, D. (2000). Use of atropine eye drops for clozapine induced hypersalivation. Australian and New Zealand Journal of Psychiatry, 34, 1033-1034.
8. Copp, P.J., Lament, R., & Tennent, T.G.(1991). Amitriptyline in clozapine-induced sialorrhea. British Journal of Psychiatry, 159, 166.
9. Corrigan, F.M., MacDonald, S., & Reynolds, G.P. (1995). Clozapine-induced hypersalivation and the alpha 2 adrenoreceptor. British Journal of Psychiatry, 167, 412.
10. Davydov, L., & Botts, S.R (2000). Clozapine-induced hypersalivation. The Annals of Pharmacotherapy, 34, 662-665.
11. Fischer, R.B., & Eichhorn, M. (2001). What to do in neuroleptic-induced sialorrhea. Psychiatrische Praxis, 28, 249-250.
12. Friedman, L.J., Tabb, S.E., Worthington, J.J., e.a. (1991). Clozapine - a novel antipsychotic agent. The New England Journal of Medicine, 15, 518-519.
13. Fritze, J., & Elliger, T. (1995). Pirenzepine for clozapine-induced hypersalivation. The Lancet, 346, 1034.
14. Grabowski, J. (1992). Clonidine treatment of clozapine-induced hypersalivation. Journal of Clinical Psychopharmacology, 12, 69-70.
15. Jann, M.W. (1991). Clozapine. Pharmacotherapy, 11, 179-195.
16. Kahl, K.G., Hagenah, J., Zapf, S., e.a. (2004). Botulinum toxin as an effective treatment of clozapine-induced hypersalivation. Psychopharmacology, 173, 229-230.
17. McCarthy, R.H., & Terkelsen, K.G. (1994). Esophageal dysfunction in two patients after clozapine treatment. Journal of Clinical Psychopharmacology, 14, 281-283.
18. Miller, D.D. (2000). Review and management of clozapine side effects. Journal of Clinical psychiatry, 61(Suppl. 8), 14-17.
19. Pearlman, C. (1994). Clozapine, nocturnal sialorrhea, and choking. Journal of Clinical Psychopharmacology, 14, 283.
20. Rabino witz, T., Frankenburg, F.R., Centorrino, F., e.a. (1996). The effect of clozapine on saliva flow rate: a pilot study. Biological Psychiatry, 40, 1132-1134.
21. Reinstein, M.J., Sirotovskaya, L.A., Chasanov, M.A., e.a. (1999). Comparative efficacy and tolerability of benztropine and terazosin in the treatment of hypersalivation secundary to clozapine. Clinical Drug Investigation, 17, 97-102.
22. Rogers, D.P., & Shramko, J.K. (2000). Therapeutic options in the treatment of clozapine-induced sialorrhea. Pharmacotherapy, 20, 1092-1095.
23. Sleutjes, F.M.A.M., & Hermens, W.A.J.J. (2002). Een bijwerking van clozapine. Speculaties over speekselvloed. Pharmaceutisch weekblad, 137, 982-985.
24. Spivak, B., Adlersberg, S., Rosen, L., e.a. (1997). Trihexyphenidyl treatment of clozapine-induced hypersalivation. International Clinical Psychopharmacology, 12, 213-215.
25. Szabadi, E. (1997). Clozapine-induced hypersalivation. British Journal of Psychiatry, 172, 89.
26. Zorn, S.H., Jones, S.B., Ward, K.M., e.a. (1994). Clozapine is a potent and selective muscarinic M4 receptor agonist. European Journal of Pharmacology, 269, R1-R2.